AdBIOPRO receives positive decision for funding of a new 5-year period

AdBIOPRO was reviewed by Vinnova’s external committee of international members of expertise in innovation and technology before the summer. Out of the eight Competence Centers that started 2017, AdBIOPRO is one of the centers that has been recommended to get financing for a new period. The final decision on the continued financing will be made by Vinnova by the end of October 2022.

” This is very exciting” says Veronique Chotteau, Director of AdBIOPRO. “We are planning now the next 5-years period, which will consolidate our work within continuous bioprocessing introducing more Process Analytical Technology (PAT) to support digital twins, increasing bioprocessing towards cell and gene therapies and including new technologies. We are also very glad to see that many new companies will join the Centre, both end-users and providers of material and equipment.”

Extracted from the evaluation of AdBIOPRO by the international Vinnova panel:

AdBIOPRO is one of very few academic centres in the world focusing on continuous bioproduction, and probably the only one with such a broadness of scope and collaborations. The centre had been able to develop collaborations nationally and internationally as shown by the number of contacts established with top academic institutions in Sweden and abroad and many companies.

The high-quality science, education and competence sharing of AdBIOPRO are very relevant for Swedish industry and its international competitiveness, and for the society in large (patients, health system) as it facilitates for new biopharmaceuticals, produced more economically and more sustainable.

AdBIOPRO is designed to build an academic foundation for an important Pharma 4.0 area for integrated, continuous bioproduction. This field is of strategic importance for the Swedish Government and the industry.

Contact: Veronique Chotteau, Director of AdBIOPRO - chotteau@kth.se